Charts of the Day: BlackBerry, Oracle, Arena Pharmaceuticals

BlackBerry teaming up with Microsoft to make phones more secure; Oracle reported earnings and revenue beat, forecast disappointed investors; Arena Pharma shares soar off positive phase 2 trial results for its experimental colitis treatment